landiolol has been researched along with Liver Dysfunction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Munakata, A; Sakamoto, J; Suto, K; Suto, T; Takahata, T; Tateishi, T; Yasui-Furukori, N | 1 |
1 trial(s) available for landiolol and Liver Dysfunction
| Article | Year |
|---|---|
Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra-short-acting beta1-blocker.
Topics: Adrenergic beta-Antagonists; Aged; Female; Heart Rate; Humans; Infusions, Intravenous; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged; Morpholines; Receptors, Adrenergic, beta-1; Urea | 2005 |